1Proudfoot AE, Handel TM, Johnson Z, et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci USA, 2003, 100 : 1885 - 1890.
2Marino AP, Silva AA, Santos PV, et al. CC-chemokine receptors : a potential therapeutic target for Trypanosoma cruzielicited myocarditis. Mem Inst Oswaldo Cruz, 2005, 100( Suppl 1 ) : 93 - 96.
3Sigrist S, Oberholzer J, Bohbot A, et al. Activation of human macrophages by allogeneic islets preparations: inhibition by AOP-RANTES and heparinoids. Immunology, 2004,111 : 416- 421.
4Vielhauer V, Berning E, Eis V, et al. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney Int, 2004,66 : 2264 - 2278.
5Schols D. HIV co-receptors as targets for antiviral therapy.Curr Top Med Chem, 2004, 4 : 883 - 893.
6Ferreira MA. Cytokine expression in allergic inflammation:systematic review of in vivo challenge studies. Mediators Inflamm, 2003, 12 : 259 -267.
7Johnson Z, Kosco-Vilbois MH, Herren S, et al. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J Immunol, 2004, 173 : 5776 - 5785.
8Jennes W, Sawadogo S, Koblavi-Deme S, et al. Cellular human immunodeficicncy virus (HIV)-protective factors: a comparison of HIV-exposed seronegative female sex workers and female blood donors in Abidjan, Cote dlvoire. J Infect Dis, 2003, 187 : 206-214.
9Zhao XY, Lee SS, Wong KH, et al. Effects of single nucleotide polymorphisms in the RANTES promoter region in healthy and HIV-infected indigenous Chinese. Eur J Immunogenet, 2004, 31 : 179 - 183.
10Lee JB, Matsumoto T, Shin YO, et al. The role of RANTES in a murine model of food allergy. Immunol Invest,2004, 33 : 27 -38.
